Capitolis Advisors LLC Baxter International Inc Transaction History

Capitolis Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$76.85 - $89.45 $4.72 Million - $5.5 Million	-61,473 Reduced 78.87%	16,473 $1.28 Million
Q4 2021 Feb 11, 2022	BUY	$74.57 - $87.19 $5.81 Million - $6.8 Million	77,946 New	77,946 $6.69 Million
Q2 2021 Aug 11, 2021	SELL	$80.5 - $88.01 $767,567 - $839,175	-9,535 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$76.38 - $86.03 $1.52 Million - $1.72 Million	-19,959 Reduced 67.67%	9,535 $804,000
Q4 2020 May 07, 2021	BUY	$75.39 - $82.36 $2.22 Million - $2.43 Million	29,494 New	29,494 $2.37 Million

998

450M

1.97M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17.5B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Capitolis Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Capitolis Advisors LLC with notifications on news.